NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

BNTX

BioNTech SE ADR

Apr 25 • 04:00PM ET

102.02

Dollar change -18.52
Percentage change -15.36	%

Healthcare • Biotechnology • Germany • NASD

Peers: MRNA PFE NVAX AZN JNJ GSK BMY GILD LLY SNY

| Held by: IBB FBT FNDF BBH SPDW TCAF IDNA QQQJ ONEQ GNOM

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-3.04	Insider Own	1.56%	Shs Outstand	239.97M	Perf Week	3.30%
Market Cap	24.48B	Forward P/E	-	EPS next Y	-5.44	Insider Trans	0.00%	Shs Float	236.22M	Perf Month	6.38%
Income	-717.19M	PEG	-	EPS next Q	-2.57	Inst Own	20.68%	Short Float	1.84%	Perf Quarter	-13.64%
Sales	2.98B	P/S	8.22	EPS this Y	-89.96%	Inst Trans	13.63%	Short Ratio	4.58	Perf Half Y	-7.99%
Book/sh	83.76	P/B	1.22	EPS next Y	9.17%	ROA	-2.94%	Short Interest	4.34M	Perf Year	15.29%
Cash/sh	70.38	P/C	1.45	EPS next 5Y	-17.64%	ROE	-3.38%	52W Range	76.53 - 131.49	Perf YTD	-10.47%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-25.87%	ROI	-3.53%	52W High	-22.41%	Beta	1.28
Dividend TTM	-	Quick Ratio	7.34	Sales past 5Y	841.54%	Gross Margin	80.37%	52W Low	33.31%	ATR (14)	7.44
Dividend Ex-Date	Jun 02, 2022	Current Ratio	7.45	EPS Y/Y TTM	-172.62%	Oper. Margin	-23.20%	RSI (14)	50.69	Volatility	10.27% 6.79%
Employees	6772	Debt/Eq	0.01	Sales Y/Y TTM	-27.64%	Profit Margin	-24.07%	Recom	1.50	Target Price	140.48
Option/Short	Yes / Yes	LT Debt/Eq	0.01	EPS Q/Q	-43.34%	Payout	-	Rel Volume	6.79	Prev Close	120.54
Sales Surprise	5.04%	EPS Surprise	143.44%	Sales Q/Q	-20.19%	Earnings	May 05 BMO	Avg Volume	947.49K	Price	102.02
SMA20	4.68%	SMA50	-1.37%	SMA200	-3.71%	Trades		Volume	6,438,028	Change	-15.36%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-13-25	Initiated	Citigroup	Buy	$145
Jan-10-25	Initiated	Truist	Buy	$172
Dec-11-24	Initiated	Wells Fargo	Overweight	$170
Dec-02-24	Reiterated	BMO Capital Markets	Outperform
Nov-19-24	Upgrade	Evercore ISI	In-line → Outperform	$110 → $125
Nov-19-24	Initiated	Berenberg	Buy	$130
Nov-08-24	Upgrade	Goldman	Neutral → Buy	$90 → $137
Sep-24-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$93 → $145
Sep-17-24	Upgrade	Jefferies	Hold → Buy	$96 → $150
Sep-16-24	Upgrade	JP Morgan	Underweight → Neutral	$91 → $125
Aug-07-24	Upgrade	Deutsche Bank	Hold → Buy	$95
Aug-02-24	Upgrade	HSBC Securities	Hold → Buy
May-14-24	Initiated	Evercore ISI	In-line	$100
Feb-23-24	Initiated	BMO Capital Markets	Outperform	$127
Jan-05-24	Initiated	Oppenheimer	Perform
Dec-01-23	Downgrade	JP Morgan	Neutral → Underweight	$106 → $99
Oct-16-23	Downgrade	HSBC Securities	Buy → Hold	$124 → $111
Jul-14-23	Initiated	HSBC Securities	Buy	$124
May-17-23	Upgrade	Redburn	Neutral → Buy	$165 → $170
Dec-15-22	Upgrade	BofA Securities	Neutral → Buy	$239

Show Previous Ratings

Today 12:50PM	Akeso survival data for ivonescimab misses expectations, STAT says (TipRanks)
09:30AM	Summit Therapeutics: New Ivonescimab Data Raise Concerns (Seeking Alpha)
Apr-25-25 05:05PM	Why Biotech Stars Summit Therapeutics and BioNTech Plunged, Even as This Chinese Rival Surged Today (Motley Fool) -15.36%
07:06AM	Will Pfizer's Non-COVID Drugs Drive Sales Again This Earnings Season? (Zacks)
Apr-24-25 06:45AM	BioNTech to Present Clinical and Preclinical Data Across mRNA and Next-Generation Immuno-Oncology Priority Programs at AACR 2025 (GlobeNewswire)
01:48AM	Loading…
01:48AM	Novavax (NVAX) Surges 19.5%: Is This an Indication of Further Gains? (Zacks)
Apr-23-25 04:10PM	BioNTech Surges On Summit's Coattails. But Can They Take On Merck? (Investor's Business Daily) +9.70%
06:58AM	Pfizer Stock Before Q1 Earnings Release: To Buy or Not to Buy? (Zacks)
Apr-22-25 07:37PM	Analyst Report: BioNTech SE (Morningstar Research)
06:45AM	BioNTech to Report First Quarter 2025 Financial Results and Corporate Update on May 5, 2025 (GlobeNewswire)
Apr-21-25 05:02PM	BioNTech SE (BNTX) Q4 2024 Earnings Call Highlights: Navigating Challenges and Advancing Innovations (GuruFocus.com)
Apr-20-25 11:28AM	IDNA: The Cutting Edge Of Medical Science Is A Risky Investment (Seeking Alpha)
Apr-15-25 09:01AM	Strength Seen in BioNTech (BNTX): Can Its 6.0% Jump Turn into More Strength? (Zacks)
Apr-14-25 09:10AM	Zai Lab Limited (ZLAB) Moves 21.5% Higher: Will This Strength Last? (Zacks) +6.03%
09:08AM	Summit Therapeutics: Multibillion Dollar NSCLC Potential Faces Growing Competition (Seeking Alpha)
05:57AM	Loading…
05:57AM	Here's Why Summit Therapeutics Stock Soared 15% on Friday (Zacks)
Apr-11-25 08:39AM	Novavax: Regulatory Uncertainty Creates Risk And Opportunity For Beaten-Down Vaccine Developer (Seeking Alpha)
Apr-10-25 09:44AM	Pfizer Stock Falls to New 52-Week Low: Should You Buy the Dip? (Zacks)
Apr-09-25 05:00AM	Barbara Weber, M.D., Elected to ITM Supervisory Board (GlobeNewswire) +8.64%
Apr-02-25 03:37PM	Is BioNTech SE (BNTX) the Best German Stock to Buy According to Hedge Funds? (Insider Monkey)
Mar-31-25 05:15PM	FDA Shake-Up Rocks Moderna Stock As Regulatory Risks Mount (Downgrade) (Seeking Alpha)
09:57AM	Moderna, biotech stocks slide following resignation of FDA official Peter Marks (Yahoo Finance)
Mar-28-25 03:24PM	CureVac: Patent Win Notable, But Won't Answer More Fundamental Questions (Seeking Alpha)
Mar-25-25 05:40PM	Is BioNTech SE (BNTX) a Promising Biotech Stock According to Wall Street Analysts (InsiderMonkey)
Mar-24-25 09:25PM	Barrons 10 Favorite Stocks for 2024 (Barrons.com) +5.51%
Mar-21-25 03:03AM	Autolus Therapeutics PLC (AUTL) Q4 2024 Earnings Call Highlights: Financial Growth Amid Rising Costs (GuruFocus.com)
Mar-20-25 08:02PM	Analyst Report: BioNTech SE (Morningstar Research)
05:49PM	Former Texas congressman Burgess eyed as CDC director nominee - report (SeekingAlpha)
Mar-11-25 01:02AM	Q4 2024 Biontech SE Earnings Call (Thomson Reuters StreetEvents) -6.61%
Mar-10-25 09:21PM	Analyst Report: BioNTech SE (Morningstar Research)
03:15PM	Loading…
03:15PM	BioNTech Se (BNTX) Q4 2024 Earnings Call Transcript (Motley Fool)
11:48AM	BioNTech Stock Drops as Sales Outlook Disappoints (Investopedia)
06:55AM	BioNTech Announces Fourth Quarter and Full Year 2024 Financial Results and Corporate Update (GlobeNewswire)
Mar-08-25 11:21AM	CDC plans study into potential vaccines, autism connections, Reuters reports (TipRanks)
Mar-07-25 04:04PM	Why Moderna Stock Has Surged 15% This Week Despite Mixed News (Investor's Business Daily)
Mar-05-25 01:06PM	Why Moderna (MRNA) Stock Is Rallying Today (Insider Monkey)
01:05PM	Moderna Scores Legal Victory Over Pfizer, BioNTech in Patent Dispute (GuruFocus.com)
10:30AM	FDA puts clinical hold on BioNTechs malaria vaccine trial (Clinical Trials Arena)
10:02AM	German court rules Pfizer, BioNTech violated Moderna's COVID-19 vaccine patent (Reuters)
Mar-04-25 01:00AM	Blocking PD-1 and VEGF: The bispecific cancer drugs that could best Keytruda (BioPharma Dive)
Mar-01-25 02:41PM	Is BioNTech SE (BNTX) The Best Immunology Stock To Buy Now? (Insider Monkey)
Feb-27-25 06:48PM	Analyst Report: BioNTech SE (Morningstar Research)
Feb-26-25 10:36AM	BioNTech SE (BNTX): Among the Best Vaccine Stocks to Buy According to Hedge Funds (Insider Monkey)
Feb-24-25 06:45AM	BioNTech to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on March 10, 2025 (GlobeNewswire)
Feb-13-25 12:00PM	What Makes BioNTech (BNTX) a New Buy Stock (Zacks) +9.73%
Feb-06-25 07:45AM	Oncology vaccine trial sees all patients living kidney cancer-free (Clinical Trials Arena)
07:45AM	BioNTechs oncology vaccine trial sees all patients living kidney cancer-free (Clinical Trials Arena)
Feb-04-25 04:13PM	RFK Jr. Clears A Key Hurdle To Head Up HHS. Why His Nomination Is A Biotech Black Box. (Investor's Business Daily)
11:55AM	Health, pharma stocks fall as RFK Jr. clears crucial vote (Yahoo Finance Video)
Feb-03-25 04:25PM	MHRA seeks input on new regulatory guidance for cancer vaccines (Pharmaceutical Technology)
06:45AM	BioNTech Completes Acquisition of Biotheus (GlobeNewswire)
Jan-24-25 04:14PM	Moderna Yo-Yos After European Officials Ink Supply Deal For Covid Shots (Investor's Business Daily)
Jan-22-25 04:52AM	3 Dirt-Cheap Stocks to Buy in a Market That's Priced for Perfection (Motley Fool)
Jan-17-25 09:55AM	Wall Street Analysts Predict a 25.59% Upside in BioNTech (BNTX): Here's What You Should Know (Zacks)
Jan-14-25 06:45AM	BioNTech Provides Business and Pipeline Updates at 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Jan-10-25 02:54PM	BioNTech Positioned For Solid Growth Amid Oncology Transition: Analyst (Benzinga)
Jan-07-25 04:12PM	Moderna, BioNTech, Novavax Surge After CDC Reports Two-Week Covid Spike (Investor's Business Daily) +5.55%
Jan-01-25 03:30AM	Drug-Trial Results Could Shake Up Pharma Stocks in 2025. Watch Eli Lilly, Pfizer, and More. (Barrons.com)
Dec-31-24 08:30AM	NIH settlement manageable headwind for BioNTech, Pfizer, says Morgan Stanley (TipRanks)
Dec-28-24 09:40AM	BioNTech to pay $467M in settlement agreement with University of Pennsylvania (TipRanks)
09:35AM	BioNTech to pay $791.5M in settlement agreement with the NIH (TipRanks)
07:47AM	BioNTech Settles Royalty Dispute with NIH for $791.5 Million (TipRanks)
07:47AM	BioNTech Settles Royalty Dispute with University of Pennsylvania (TipRanks)
Dec-27-24 10:11AM	BioNTech's Big Moves: $1.2 Billion Settlements and a Game-Changing Cancer Bet (GuruFocus.com)
07:53AM	BioNTech enters settlement with US agency, UPenn over COVID vaccine royalties (Reuters)
Dec-26-24 09:45AM	2 Reasons to Sell Merck Stock and 1 Reason to Buy (Motley Fool)
Dec-18-24 05:44AM	3 No-Brainer Biotech Stocks to Buy With $200 Right Now (Motley Fool)
Dec-11-24 05:50AM	2 Healthcare Stocks to Buy Hand Over Fist and 1 to Avoid (Motley Fool)
Dec-09-24 05:50AM	2 No-Brainer Stocks to Buy Before the End of 2024 (Motley Fool)
Dec-06-24 01:14PM	Why Is BioNTech Stock Trading Higher On Friday? (Benzinga)
Dec-04-24 05:45AM	5 Top Stocks to Buy in December (Motley Fool)
Dec-02-24 02:51PM	Why Is BioNTech SE (BNTX) Among the Best High Growth Healthcare Stocks to Invest In Now? (Insider Monkey)
07:50AM	Analyst Report: BioNTech SE (Morningstar Research)
Nov-27-24 07:01AM	BioNTech price target lowered to $122 from $124 at JPMorgan (TipRanks)
Nov-25-24 06:48PM	Analyst Report: BioNTech SE (Morningstar Research) +6.74%
Nov-20-24 05:20AM	BioNTech upgraded to Outperform from In Line at Evercore ISI (TipRanks)
05:00AM	Moderna initiated with a Hold at Berenberg (TipRanks)
04:55AM	BioNTech initiated with a Buy at Berenberg (TipRanks)
Nov-19-24 06:15PM	Is BioNTech SE (BNTX) the Best German Stock to Buy Now? (Insider Monkey)
11:57AM	BioNTech Stock Has Been Hit Hard Since RFK Jr.s Nomination. Why This Analyst Upgraded It. (Barrons.com)
Nov-18-24 12:48AM	Analyst Report: BioNTech SE (Morningstar Research)
Nov-15-24 04:19PM	Pfizer, Moderna, BioNTech Take A Beating After Trump Taps Kennedy To Head Up HHS (Investor's Business Daily)
12:04PM	Pfizer, Moderna, Novavax Take A Beating After Trump Taps Kennedy To Head Up HHS (Investor's Business Daily)
11:15AM	Trumps RFK Jr. Pick Weighs on Vaccine Makers (The Wall Street Journal)
10:46AM	Trump looks to end EV credit, vaccine stocks fall on RFK JR. pick (Yahoo Finance Video)
08:14AM	BioNTech SEs Strategic Growth in Oncology and mRNA (TipRanks)
Nov-14-24 04:32AM	BioNTech signs agreement to acquire Biotheus (Pharmaceutical Technology) -7.10%
Nov-13-24 02:58PM	BioNTech to Acquire Biotheus for $800 Million to Expand Oncology Portfolio (GuruFocus.com)
01:08PM	BioNTech Boosts Oncology Strategy With $800 Million+ China-Based Biotheus Acquisition (Benzinga)
06:45AM	BioNTech to Acquire Biotheus to Boost Oncology Strategy (GlobeNewswire)
01:45AM	BioNTech to buy Biotheus, gaining control of cancer bispecific (BioPharma Dive)
Nov-09-24 02:12PM	BioNTech Earns Upgrade From Goldman Sachs As Investment Thesis Shifts Toward Cancer Potential (Benzinga)
Nov-06-24 01:15PM	Vaccine Stocks Drop on Worries About an RFK Jr. Role (The Wall Street Journal)
Nov-05-24 07:17AM	BioNTechs Q3 2024: Strong Revenue and Oncology Progress (TipRanks)
07:17AM	BioNTech SE Reports Strong Revenue Growth Amid Rising R&D Costs (TipRanks)
03:28AM	Q3 2024 BioNTech SE Earnings Call (Thomson Reuters StreetEvents)
02:02AM	BioNTech SE (BNTX) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic Advancements ... (GuruFocus.com)
12:10AM	Analyst Report: BioNTech SE (Morningstar Research)
Nov-04-24 06:39PM	Analyst Report: BioNTech SE (Morningstar Research)
04:04PM	BioNTech Nears A Sell Signal After Cutting Outlook Despite Massive Sales Beat (Investor's Business Daily)

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	SEC Form 4
Richardson Ryan	Officer	Feb 27 '25	Proposed Sale	114.00	26,500	3,021,000	Feb 27 07:57 AM
Medine GmbH	Officer	Feb 20 '25	Proposed Sale	119.58	1,000,000	119,580,000	Feb 20 07:53 AM
Poetting Sierk	Officer	Feb 20 '25	Proposed Sale	119.58	120,000	14,349,600	Feb 20 07:50 AM
ATHOS KG	10% Owner	Dec 13 '24	Proposed Sale	120.69	4,983	601,398	Dec 13 05:56 PM
ATHOS KG	10% Owner	Dec 11 '24	Proposed Sale	116.85	22,450	2,623,283	Dec 11 05:25 PM
ATHOS KG	10% Owner	Dec 09 '24	Proposed Sale	121.72	53,716	6,538,312	Dec 09 06:35 PM
ATHOS KG	10% Owner	Dec 06 '24	Proposed Sale	118.84	13,104	1,557,279	Dec 06 05:57 PM
ATHOS KG	10% Owner	Nov 27 '24	Proposed Sale	118.54	44,374	5,260,094	Nov 27 05:50 PM
ATHOS KG	10% Owner	Nov 26 '24	Proposed Sale	120.76	10,000	1,207,600	Nov 26 06:37 PM
ATHOS KG	10% Owner	Nov 25 '24	Proposed Sale	113.13	75,000	8,484,750	Nov 25 05:06 PM
Jeggle Helmut Wolfgang	Director	Nov 15 '24	Proposed Sale	103.56	150,000	15,534,000	Nov 15 05:12 PM
Tureci Ozlem	Officer	Nov 12 '24	Proposed Sale	108.73	556,000	60,453,880	Nov 12 07:39 AM
ATHOS KG	10% Owner	Oct 16 '24	Proposed Sale	117.74	8,036	946,154	Oct 16 05:03 PM
ATHOS KG	10% Owner	Oct 14 '24	Proposed Sale	120.83	25,424	3,071,964	Oct 15 08:41 AM
ATHOS KG	10% Owner	Oct 11 '24	Proposed Sale	120.13	40,000	4,805,228	Oct 11 04:15 PM
ATHOS KG	10% Owner	Oct 10 '24	Proposed Sale	117.47	20,000	2,349,436	Oct 10 04:13 PM
ATHOS KG	10% Owner	Oct 09 '24	Proposed Sale	119.06	6,000	714,361	Oct 09 04:02 PM
ATHOS KG	10% Owner	Oct 08 '24	Proposed Sale	122.01	15,000	1,830,100	Oct 08 04:24 PM
ATHOS KG	10% Owner	Oct 04 '24	Proposed Sale	122.80	14,756	1,812,078	Oct 04 04:17 PM
ATHOS KG	10% Owner	Oct 03 '24	Proposed Sale	119.27	50,000	5,963,585	Oct 03 05:14 PM
ATHOS KG	10% Owner	Oct 02 '24	Proposed Sale	119.04	65,200	7,761,193	Oct 02 06:18 PM
ATHOS KG	10% Owner	Oct 01 '24	Proposed Sale	119.24	72,086	8,595,657	Oct 01 04:18 PM
ATHOS KG	10% Owner	Sep 30 '24	Proposed Sale	118.22	76,114	8,998,197	Sep 30 04:52 PM
ATHOS KG	10% Owner	Sep 27 '24	Proposed Sale	117.64	37,204	4,376,679	Sep 27 05:12 PM
ATHOS KG	10% Owner	Sep 25 '24	Proposed Sale	118.47	37,943	4,495,107	Sep 25 07:14 PM
ATHOS KG	10% Owner	Sep 18 '24	Proposed Sale	124.71	55,605	6,934,500	Sep 18 07:28 PM
ATHOS KG	10% Owner	Sep 17 '24	Proposed Sale	124.49	30,162	3,754,792	Sep 17 04:14 PM
ATHOS KG	10% Owner	Sep 16 '24	Proposed Sale	123.40	500,000	61,700,000	Sep 16 05:35 PM
ATHOS KG	10% Owner	Sep 16 '24	Proposed Sale	126.02	90,000	11,341,611	Sep 16 04:12 PM
ATHOS KG	10% Owner	Sep 13 '24	Proposed Sale	115.02	170,000	19,552,584	Sep 13 04:12 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BNTX

BioNTech SE ADR

Upgrade your FINVIZ experience